Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2005 Abstracts: Treatment with Sirolimus and Intraoperative Hyperthermic Chemoperfusion with Mitomycin C Do Not Alter Anastomotic Stability in Healthy Pigs
Back to 2005 Posters
Back to 2005 Program and Abstracts
Treatment with Sirolimus and Intraoperative Hyperthermic Chemoperfusion with Mitomycin C Do Not Alter Anastomotic Stability in Healthy Pigs
Oliver J. Wagner, Roman Inglin, Markus Borner, Daniel Candinas, Bernhard Egger, Department of Visceral and Transplant Surgery, Bern, Bern, Switzerland

Introduction: Wound healing complications are frequently observed in transplant patients under a immunosuppressive regimen with sirolimus and administration of mycophenolate mofetil has been demonstrated to impair healing of colonic anastomoses. Intraperitoneal hyperthermic chemoperfusion (IHCP) reduces progression of peritoneal carcinomatosis following oncological surgery but leads to an increased leakage rate of intestinal anastomoses. Administration of Insulin-like growth factor-I (IGF-I) and truncated keratinocyte growth factor (tKGF) improves healing of bowel anastomosis in rats (Br J Surg 2001;88:90). The aim of the present study was to evaluate whether IGF-I or tKGF may prevent anastomotic healing problems in pigs undergoing IHCP with/without sirolimus administration. Materials/Methods: 24 pigs were divided into 4 groups (A-D). Sirolimus was administered orally during 7 days prior to surgery (15mg/d) and after surgery (5mg/d) until sacrifice on postoperative day 4. Laparatomy and division of bowel was performed followed by intramucosal injections of IGF-I (A: 5mg), tKGF (B: 5mg), vehicle IGF-I (C) or vehicle tKGF (D) into the bowel dissection margins. Suturing bowel anastomosis was followed by IHPC with a Mitomycin-C solution (4 Liters; 10mg/L,41.5°C, 1h). 18 additional control pigs (n=6 group E-G) received either +sirolimus, +NaCl-injection, +isothermic NaCl-perfusion (E), or –sirolismus, +NaCl-injection, +IHPC (F) or –sirolimus, +NaCl-injection, +isothermic NaCl-perfusion (G). Mechanical stability of anastomosis was evaluated by measuring the bursting pressure (BP). Results: In all experimental and control groups BP's [mmHg; mean ± SEM] were statistically not different: Group A: 95±61 in the small intestine vs. 112±13 in the colon, B: 100±34 vs. 90±26, C: 132±48 vs. 96±10 and D: 160±36 vs. 104±14. BP's of anastomoses were comparable to those observed in the additional control groups (E-G): E: 135±50 vs. 90±15, F: 146±28 vs. 90±35 and G: 130±40 vs. 98±18. Conclusions: Administration of sirolimus with/without IHPC does not impair mechanical stability of bowel anastomoses in healthy pigs. Since bursting pressures did not differ between experimental and control groups our experiments were unable to demonstrate a beneficial effect of locally applied IGF-I and tKGF. However, immunosuppression with sirolimus, that is often associated with wound healing complications in humans, does not impair mechanical stability of intestinal anastomosis in pigs.



Back to 2005 Posters
Back to 2005 Program and Abstracts


Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards